Regulatory Forum: U.S. Food and Drug Administration (FDA)

The Foundation will convene an ongoing working group to discuss FDA regulations, with participation from industry representatives and the FDA. Key issues from the FDA working group will be presented at the annual conference, and summarized in white papers available on this website.

Regulatory Forum: Healthcare Reimbursement

The Foundation will convene an ongoing working group to discuss healthcare reimbursement and Centers for Medicare & Medicaid Services (CMS) issues, with participation from industry representatives, private insurance and governmental agencies. Key issues from the Reimbursement and CMS working group will be presented at the annual conference, and summarized in white papers available on this website.